David B Snyder

Title: David B Snyder: Innovator in Infectious Disease Research

Introduction

David B Snyder is a prominent inventor based in Bowie, MD (US). He has made significant contributions to the field of infectious disease research, holding a total of 8 patents. His work primarily focuses on the development of monoclonal antibodies and vaccines for infectious bursal disease.

Latest Patents

Among his latest patents are innovative solutions for infectious bursal disease. One notable patent involves monoclonal antibodies that neutralize all infectious bursal disease viruses. These antibodies are utilized in the preparation of vaccines, which are crucial for combating this disease. Another patent details chimeric infectious bursal disease virus cDNA clones, which express immunogenic polypeptides. These clones include genetic epitopic determinants from various strains of the virus, allowing for the development of vaccines that can provide immunity against multiple strains. Additionally, his research has identified immunogens that exhibit conformational epitopes, which are effective in vaccine preparation.

Career Highlights

David B Snyder is affiliated with the University System of Maryland, where he continues to advance research in infectious diseases. His work has been instrumental in developing effective vaccines and diagnostic tools that can significantly impact public health.

Collaborations

Throughout his career, David has collaborated with notable colleagues, including Vikram N Vakharia and Stephanie A Mengel-Whersat. These collaborations have further enhanced the scope and impact of his research.

Conclusion

David B Snyder's contributions to the field of infectious disease research are invaluable. His innovative patents and collaborative efforts continue to pave the way for advancements in vaccine development and disease prevention.